{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:56:00Z","timestamp":1790009760932,"version":"4.0.1"},"reference-count":10,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,9]],"date-time":"2015-04-09T00:00:00Z","timestamp":1428537600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.jaad.2015.04.010","type":"journal-article","created":{"date-parts":[[2015,5,5]],"date-time":"2015-05-05T08:47:06Z","timestamp":1430815626000},"page":"62-69","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":153,"title":["Efficacy and safety of tavaborole topical solution, 5%, a novel boron-based antifungal agent, for the treatment of toenail onychomycosis: Results from 2 randomized phase-III studies"],"prefix":"10.1016","volume":"73","author":[{"given":"Boni E.","family":"Elewski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raza","family":"Aly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheryl L.","family":"Baldwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remigio F.","family":"Gonz\u00e1lez Soto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phoebe","family":"Rich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Weisfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hector","family":"Wiltz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee T.","family":"Zane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Pollak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2015.04.010_bib1","series-title":"Kerydin [package insert]","year":"2014"},{"key":"10.1016\/j.jaad.2015.04.010_bib2","series-title":"Lamisil [package insert]","year":"2013"},{"key":"10.1016\/j.jaad.2015.04.010_bib3","series-title":"Sporanox capsules [package insert]","year":"2012"},{"key":"10.1016\/j.jaad.2015.04.010_bib4","series-title":"Penlac [package insert]","year":"2006"},{"key":"10.1016\/j.jaad.2015.04.010_bib5","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1126\/science.1142189","article-title":"An antifungal agent inhibits an aminoacyl-tRNA synthetase by trapping tRNA in the editing site","volume":"316","author":"Rock","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.jaad.2015.04.010_bib6","first-page":"662","article-title":"AN-2690, a novel antifungal for the topical treatment of onychomycosis","volume":"8","author":"Barak","year":"2007","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.jaad.2015.04.010_bib7","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1002\/jps.20901","article-title":"In\u00a0vitro penetration of a novel oxaborole antifungal (AN2690) into the human nail plate","volume":"96","author":"Hui","year":"2007","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.jaad.2015.04.010_bib8","unstructured":"Hold KM, Sanders V, Bu W, et\u00a0al. Nail penetration and nail concentration of AN2690, a novel broad-spectrum antifungal agent in development for the topical treatment of onychomycosis. Poster presented at the Annual Meeting of the American Association of Pharmaceutical Scientists; October 29-November 2, 2006; San Antonio, TX."},{"key":"10.1016\/j.jaad.2015.04.010_bib9","unstructured":"Zane LT, Pollak RA. Safety and efficacy of tavaborole (formerly\u00a0AN2690), a novel boron-based molecule, in phase 2 trials for the topical treatment of toenail onychomycosis. Poster presented at the Annual Scientific Meeting of the American Podiatric Medical Association; August 16-19, 2012; Washington, DC."},{"key":"10.1016\/j.jaad.2015.04.010_bib10","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1517\/14656566.2014.921158","article-title":"Tavaborole for the treatment of onychomycosis","volume":"15","author":"Elewski","year":"2014","journal-title":"Expert Opin Pharmacother"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962215015121?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962215015121?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:34:19Z","timestamp":1759271659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962215015121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S0190962215015121"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2015.04.010","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725481179.793561574","asserted-by":"object"}]},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of tavaborole topical solution, 5%, a novel boron-based antifungal agent, for the treatment of toenail onychomycosis: Results from 2 randomized phase-III studies","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2015.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American Academy of Dermatology, Inc. Published by Mosby, Inc.","name":"copyright","label":"Copyright"}]}}